Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055704 · ClinicalTrials.gov registry record · Phase 4
Effect of Methylnaltrexone on GI Transit in Healthy Volunteers
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT01055704: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT01055704 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01055704, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
This is a single-center, randomized, double blind, placebo-controlled study evaluating the effects of placebo, codeine, methylnaltrexone and codeine with methylnaltrexone on gastrointestinal motility and colonic transit of solids in healthy human subjects. The hypotheses are: 1. Methylnaltrexone administered subcutaneously enhances gastrointestinal motility with acceleration of overall colonic transit, and ascending colon emptying of solids in healthy humans. 2. Methylnaltrexone significantly accelerates colonic transit that is delayed by codeine
Interventions
- DRUG Methylnaltrexone only
- DRUG Codeine only
- DRUG Methylnaltrexone + codeine
- DRUG Placebo + placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01055704
The ClinicalTrials.gov registry entry for NCT01055704 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Methylnaltrexone only is the first listed.
NCT01055704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01055704 about?
NCT01055704 is a clinical study titled "Effect of Methylnaltrexone on GI Transit in Healthy Volunteers". This is a single-center, randomized, double blind, placebo-controlled study evaluating the effects of placebo, codeine, methylnaltrexone and codeine with methylnaltrexone on gastrointestinal motility and colonic transit of solids in healthy human subjects. The hypotheses are: 1. Methylnaltrexone a...
What is the current status of trial NCT01055704?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2009-11. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01055704?
The interventions under investigation include: Methylnaltrexone only (DRUG), Codeine only (DRUG), Methylnaltrexone + codeine (DRUG), Placebo + placebo (DRUG).
Who is sponsoring clinical trial NCT01055704?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.